Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors

Journal of Medicinal Chemistry

Volumn 50, Issue 2, 2007, Pages 381-388

  Nishimori, Isao ^a   Minakuchi, Tomoko ^a   Onishi, Saburo ^a   Vullo, Daniela ^b   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BENZENESULFONAMIDE DERIVATIVE; BENZOLAMIDE; BICARBONATE; BRINZOLAMIDE; CARBON DIOXIDE; CARBONATE DEHYDRATASE; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; HYBRID PROTEIN; INDISULAM; METHAZOLAMIDE; PHENOLSULFONPHTHALEIN; PROTON; SULFANILAMIDE; SULFONAMIDE; SULPIRIDE; TOOTHPASTE; TOPIRAMATE;

ARTICLE; DENTAL CARIES; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME MECHANISM; GENE EXPRESSION SYSTEM; HYDRATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CATALYSIS; CLONING, MOLECULAR; DNA; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PROTEIN SUBUNITS; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; SULFONIC ACIDS;

EID: 33846458646     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0612057     Document Type: Article

References (57)

1. Supuran, C. T.; Scozzafava, A.; Conway, J. Carbonic Anhydrase-Its Inhibitors and Activators; CRC Press: Boca Raton, FL, 2004; pp 1-363.
2. (a) Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran C. T. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 2004, 19, 199-229.
3. (b) Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin. Ther. Pat. 2004, 14, 667-702.
4. (a) Supuran, C. T. Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In Carbonic Anhydrase-Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 1-23.
5. (b) Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-89.
6. (c) Supuran, C. T.; Scozzafava, A.; Casini, A. Development of sulfonamide carbonic anhydrase inhibitors. In Carbonic Anhydrase-Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 67-147.
7. (d) Winum, J. Y.; Montero, J. L.; Scozzafava, A.; Supuran, C. T. New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. Mini-Rev. Med. Chem. 2006, 6, 921-936.
8. (a) Smith, K. S.; Jakubzick, C.; Whittam, T. S.; Ferry, J. G. Carbonic anhydrase is an ancient enzyme widespread in prokaryotes. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 15184-15189.
9. (b) Sly, W. S.; Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase defficiencies. Annu. Rev. Biochem. 1995, 64, 375-401.
10. Lehtonen, J.; Shen, B.; Vihinen, M.; Casini, A.; Scozzafava, A.; Supuran, C. T.; Parkkila, A. K.; Saarnio, J.; Kivela, A. J.; Waheed, A.; Sly, W. S.; Parkkila, S. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J. Biol. Chem. 2004, 279, 2719-27.
11. (a) Wykoff, C. C.; Beasley, N. J.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J.; Harris, A. L. Hypoxia-inducible regulation of tumor-associated carbonic anhydrases. Cancer Res. 2000, 60, 7075-7083.
12. (b) Potter, C. P. S.; Harris, A. L. Diagnostics, prognostics and therapeutic implications of carbonic anhydrases in cancer. Br. J. Cancer 2003, 89, 2-7.
13. (a) Supuran, C. T.; Scozzafava, A. Activation of carbonic anhydrase isozymes. In The Carbonic Anhydrases-New Horizons; Chegwidden, W. R., Carter, N., Edwards, Y., Eds.; Birkhauser Verlag: Basel, Switzerland, 2000; pp 197-219.
14. (b) Ilies, M.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase activators. In Carbonic Anhydrase-Its Inhibitors and Activators, Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 317-352.
15. 2 sensing in fungi and beyond. Curr. Opin. Microbiol. 2006, 9, 1-7.
16. Hilvo, M.; Tolvanen, M.; Clark, A.; Shen, B.; Shah, G. N.; Waheed, A.; Halmi, P.; Hanninen, M.; Hamalainen, J. M.; Vihinen, M. Sly, W. S.; Parkkila, S. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem. J. 2005, 392, 83-92.
17. Nishimori, I. Acatalytic CAs: Carbonic anhydrase-related proteins. In Carbonic Anhydrase-Its Inhibitors and Activators, Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 25-43.
18. Fernley, R. T.; Wright, R. D.; Coghlan, J. P. A novel carbonic anhydrase from the ovine parotid gland. FEBS Lett. 1979, 105, 299-302.
19. (a) Aldred, P.; Fu, P.; Barrett, G.; Penschow, J. D.; Wright, R. D.; Coghlan, J. P.; Fernley, R. T. Human secreted carbonic anhydrase: cDNA cloning, nucleotide sequence, and hybridization histochemistry. Biochemistry 1991, 30, 569-75.
20. (b) Fernley, R. T. Secreted carbonic anhydrases. In Carbonic Anhydrase-From Biochemistry and Genetics to Physiology and Clinical Medicine; Botrè, F., Gros, G., Storey, B. T., Eds.; VCH: Weinheim, 1991; pp 178-185.
21. Murakami, H.; Sly, W. S. Purification and characterization of human salivary carbonic anhydrase. J. Biol. Chem. 1987, 262, 1382-1388.
22. Karhumaa, P.; Leinonen, J.; Parkkila, S.; Kaunisto, K.; Tapanainen, J.; Rajaniemi, H. The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 11604-8.
23. Ogawa, Y.; Matsumoto, K.; Maeda, T.; Tamai, R.; Suzuki, T.; Sasano, H.; Fernley, R. T. Characterization of lacrimal gland carbonic anhydrase VI. J. Histochem. Cytochem. 2002, 50, 821-7.
24. Smith, C. E.; Nanci, A.; Moffatt, P. Evidence by signal peptide trap technology for the expression of carbonic anhydrase VI in rat incisor enamel organs. Eur. J. Oral Sci. 2006, 114 (Suppl 1), 147-53.
25. Casini, A.; Antel, J.; Abbate, F.; Scozzafava, A.; David, S.; Waldeck, H.; Schafer, S.; Supuran, C. T. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg. Med. Chem. Lett. 2003, 13, 841-5.
26. Abbate, F.; Coetzee, A.; Casini, A.; Ciattini, S.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg. Med. Chem. Lett. 2004, 14, 337-41.
27. Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217-23.
28. Ilies, M. A.; Vullo, D.; Pastorek, J.; Scozzafava, A.; Ilies, M.; Caproiu, M. T.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. J. Med. Chem. 2003, 46, 2187-96.
29. Scozzafava, A.; Briganti, F.; Mincione, G.; Menabuoni, L.; Mincione, F.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route. J. Med. Chem. 1999, 42, 3690-700.
30. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/ heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? J. Med. Chem. 1999, 42, 2641-50.
31. Supuran, C. T.; Clare, B. W. Quantum theoretic QSAR of benzene derivatives: some enzyme inhibitors. J. Enzyme Inhib. Med. Chem. 2004, 19, 237-48.
32. Winum, J. Y.; Dogne, J. M.; Casini, A.; de Leval, X.; Montero, J. L.; Scozzafava, A.; Vullo, D.; Innocenti, A.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties. J. Med. Chem. 2005, 48, 2121-5.
33. (a) Nishimori I.; Vullo D.; Innocenti A.; Scozzafava A.; Mastrolorenzo A.; Supuran C. T. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J. Med. Chem. 2005, 48, 7860-6.
34. (b) Nishimori, I.; Minakuchi, T.; Morimoto, K.; Sano, S.; Onishi S.; Takeuchi, H.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori: A new target for developing sulfonamide and sulfamate gastric drugs. J. Med. Chem. 2006, 49, 2117-2126.
35. (c) Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 2003, 13, 1005-1009.
36. Menchise, V.; De Simone, G.; Alterio, V.; Di Fiore, A.; Pedone, C.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. J. Med. Chem. 2005, 48, 5721-5727.
37. Temperini, C.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: sterospecific recognition within the active site of an enzyme and its consequences for the drug design. J. Med. Chem. 2006, 49, 3019-27.
38. Tashian, R. E.; Venta, P. J.; Nicewander, P. H.; Hewett-Emmett, D. Evolution, structure, and expression of the carbonic anhydrase multigene family. Prog. Clin. Biol. Res. 1990, 344, 159-75.
39. Vullo, D.; Franchi, M.; Gallori, E.; Antel, J.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J. Med. Chem. 2004, 47, 1272-9.
40. Vullo, D.; Innocenti, A.; Nishimori, I.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-A new target for the design of antitumor and antiglaucoma drugs? Bioorg. Med. Chem. Lett. 2005, 15, 963-9.
41. (a) Nair, S. K.; Christianson, D. W. Unexpected pH-dependent conformation of His-64, the proton shuttle of carbonic anhydrase II. J. Am. Chem. Soc. 1991, 113, 9455-9458.
42. (b) Christianson, D. W.; Fierke, C. A. Carbonic anhydrase: Evolution of the zinc binding site by nature and by design. Acc. Chem. Res. 1996, 29, 331-339.
43. Nishimori, I.; Vullo, D.; Innocenti, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 3828-33.
44. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971, 246, 2561-73.
45. Khalifah, R. G.; Strader, D. J.; Bryant, S. H.; Gibson, S. M. Carbon-13 nuclear magnetic resonance probe of active-site ionizations in human carbonic anhydrase B. Biochemistry 1977, 16, 2241-7.
46. Hooper, L. V.; Beranek, M. C.; Manzella, S. M.; Baenziger, J. U. Differential expression of Ga1NAc-4-sulfotransferase and Ga1NAc-transferase results in distinct glycoforms of carbonic anhydrase VI in parotid and submaxillary glands. J. Biol. Chem. 1995, 270, 5985-93.
47. Supuran, C. T. Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat. 2000, 10, 575-600.
48. Kivela, J.; Parkkila, S.; Parkkila, A. K.; Leinonen, J.; Rajaniemi, H. Salivary carbonic anhydrase isoenzyme VI. J. Physiol. 1999, 520, 315-320.
49. (a) Leinonen, J.; Kivela, J.; Parkkila, S.; Parkkila, A. K.; Rajaniemi, H. Salivary carbonic anhydrase isoenzyme VI is located in the human enamel pellicle. Caries Res. 1999, 33, 185-190.
50. (b) Kivela, J.; Parkkila, S.; Parkkila, A. K.; Rajaniemi, H. A low concentration of carbonic anhydrase isoenzyme VI in whole saliva is associated with caries prevalence. Caries Res. 1999, 33, 178-184.
51. (c) Kivela, J.; Laine, M.; Parkkila, S.; Rajaniemi, H. Salivary carbonic anhydrase VI and its relation to salivary flow rate and buffer capacity in pregnant and non-pregnant women. Arch. Oral Biol. 2003, 48, 547-51.
52. (d) Kimoto, M.; Kishino, M.; Yura, Y.; Ogawa, Y. A role of salivary carbonic anhydrase VI in dental plaque. Arch. Oral Biol. 2006, 51, 117-22.
53. (a) Gay, C. V.; Mueller, W. J. Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography. Science 1974, 183, 432-4.
54. (b) Hunter, S. J.; Rosen, C. J.; Gay, C. V. In vitro resorptive activity of isolated chick osteoclasts: effects of carbonic anhydrase inhibition. J. Bone Miner. Res. 1991, 6, 61-66.
55. (a) Pierce, W. M., Jr.; Nardin, G. F.; Fuqua, M. F.; Sabah-Maren, E.; Stem, S. H. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J. Bone Miner. Res. 1991, 6, 347-54.
56. (b) Reginster, J. Y.; Deroisy, R.; Jupsin, I. Strontium ranelate: A new paradigm in the treatment of osteoporosis. Drugs Today (Barc.) 2003, 39, 89-101.
57. Nishimori, I.; Innocenti, A.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions. Bioorg. Med. Chem. Lett. 2007, 17, in press.